Roche (JOBS) - Genentech, Inc. (JOBS) Deal Called Close at $95 a Share

March 10, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SFGate - Roche is reportedly willing to pay Genentech $95 a share, up from the $93 that the Swiss drugmaker offered on Friday, to acquire full control of the South San Francisco biotech pioneer in what would be a $46.7 billion deal.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe

Genentech, Inc. Roche